Cite
HARVARD Citation
Galli, M. et al. (2022). Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy. European heart journal. 8 (7), pp. 728-737. [Online].